Why the Capitol Health Ltd share price has gone gangbusters today

Capitol Health Ltd (ASX:CAJ) shares are up 17% following positive news from the MYEFO. But are they a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the biggest movers on the ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) today has been Capitol Health Ltd (ASX: CAJ).

The diagnostic imaging company's shares are up 17% to 13.5 cents at the time of writing, bringing its two-day gain to a massive 20.5%.

The reason for this gain is all down to yesterday's Mid-Year Economic and Fiscal Outlook which revealed that the Federal Government plans to defer changes to the bulk-billing incentive program for diagnostic imaging until 1 July 2017 to allow for further consultation.

This is a big boost for Capitol Health which had previously advised that the changes would negatively impact revenue by between 5% and 7% in FY 2017. Pleasingly management now anticipates a jump in revenue growth in the second half of the current financial year.

However, management has warned that "the lingering uncertainty as to the exact timing and nature of cuts may further extend the recent volatility seen in referral patterns and patient volumes." Because of this it hasn't been able to fully calculate the exact impact to revenue, if of course there will ultimately be one.

Clearly this is potentially very positive news for the company, but does it make it a buy?

At just over 10x full year earnings, Capitol Health does look remarkably cheap. But the overall uncertainty over its future performance means I couldn't justify an investment today.

I would much sooner invest in healthcare companies such as ResMed Inc. (CHESS) (ASX: RMD) and Cochlear Limited (ASX: COH). Although they aren't cheap in comparison to Capitol Health, I believe the price justifies the quality of their earnings and growth prospects.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »